Brian Traver

TL;DR: Among patients admitted for worsening signs and symptoms of HF and reduced EF, congestion improves substantially during hospitalization in response to standard therapy alone, however, patients with absent or minimal restingSigns and symptoms at discharge still experienced a high mortality and readmission rate.

TL;DR: Despite close follow-up and evidence-based therapy within a clinical trial, rehospitalization and death remain high and although most deaths were from HF, one quarter of patients had SCD, and there were almost as many non-CV hospitalizations as HF hospitalizations.

TL;DR: A prolonged QRS duration appears common in patients with reduced LVEF who are hospitalized for heart failure and is an independent predictor of high postdischarge morbidity and mortality.

TL;DR: Major continental and regional differences in HF severity, etiology, and management exist among AHFS patients, resulting in varied post-discharge outcomes, despite pre-defined selection criteria.

TL;DR: Baseline renal dysfunction as well as in-hospital and post-discharge WRF were predictive of a composite endpoint of cardiovascular (CV) mortality/HF rehospitalization and worsening renal function during hospitalization as an endpoint in clinical trials should be re-evaluated.